Drug Therapy
11. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.
- Author
- Chan PS; Nallamothu BK; Gurm HS; Hayward RA; Vijan S;
- Institution
- University of Michigan Department of Internal Medicine, Ann Arbor, MI, USA. paulchan@umich.edu
- Journal
- Circulation. 2007 May 8;115(18):2398-409. Epub 2007 Apr 23.
- Abstract URL
- Click here to view abstract
12. One-month therapy with simvastatin restores endothelial function in hypercholesterolemic children and adolescents.
- Author
- Ferreira WP; Bertolami MC; Santos SN; Barros MR; de Matos Barretto RB; Pontes SC Jr; Fonseca FH; Carvalho AC;
- Institution
- Instituto Dante Pazzanese de Cardiologia, Av. Dr. Dante Pazzanese, 500 Bairro Ibirapuera, 04012-180 Sao Paulo, Brazil. wferreir@uol.com.br
- Journal
- Pediatr Cardiol. 2007 Jan-Feb;28(1):8-13. Epub 2007 Jan 25.
- Abstract URL
- Click here to view abstract
13. Treatment of hypercholesterolemia with ezetimibe in cardiac transplant recipients.
- Author
- Patel AR; Ambrose MS; Duffy GA; Cote H; DeNofrio D;
- Institution
- Heart Failure and Cardiac Transplant Center, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA. apatel@tufts-nemc.org
- Journal
- J Heart Lung Transplant. 2007 Mar;26(3):281-4.
- Abstract URL
- Click here to view abstract
14. Pravastatin reduces the risk for cardiovascular disease in Japanese hypercholesterolemic patients with impaired fasting glucose or diabetes: diabetes subanalysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study.
- Author
- Tajima N; Kurata H; Nakaya N; Mizuno K; Ohashi Y; Kushiro T; Teramoto T; Uchiyama S; Nakamura H;
- Institution
- Department of Internal Medicine, Jikei University School of Medicine 3-25-8, Nishi-Shimbashi, Minato-ku, 105-8461 Tokyo, Japan. ntajima@jikei.ac.jp
- Journal
- Atherosclerosis. 2008 Aug;199(2):455-62. Epub 2008 May 28.
- Abstract URL
- Click here to view abstract
15. Impact on cardiovascular events of increasing high density lipoprotein cholesterol with and without lipid lowering drugs.
- Author
- Wei L; Murphy MJ; MacDonald TM;
- Institution
- Health Informatics Centre, Division of Community Health Sciences, University of Dundee, Dundee, UK.
- Journal
- Heart. 2006 Jun;92(6):746-51. Epub 2005 Oct 10.
- Abstract URL
- Click here to view abstract
16. Statin-related adverse events: a meta-analysis.
- Author
- Silva MA; Swanson AC; Gandhi PJ; Tataronis GR;
- Institution
- Massachusetts College of Pharmacy and Health Sciences, Worcester, Massachusetts 01608, USA. msilva@wor.mcphs.edu
- Journal
- Clin Ther. 2006 Jan;28(1):26-35.
- Abstract URL
- Click here to view abstract
17. Low high-density lipoprotein cholesterol and cardiovascular disease: risk reduction with statin therapy.
- Author
- Rosenson RS;
- Institution
- Preventive Cardiology Center, Northwestern University, Chicago, IL, USA. r-rosenson@northwestern.edu
- Journal
- Am Heart J. 2006 Mar;151(3):556-63.
- Abstract URL
- Click here to view abstract
18. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
- Author
- Feldman T; Davidson M; Shah A; Maccubbin D; Meehan A; Zakson M; Tribble D; Veltri E; Mitchel Y;
- Institution
- Miami Research Associates, Coral Gables, Florida 33146, USA. tfeldmanmd@aol.com
- Journal
- Clin Ther. 2006 Jun;28(6):849-59.
- Abstract URL
- Click here to view abstract
19. The anti-atherosclerotic effects of lipid lowering with atorvastatin in patients with hypercholesterolemia.
- Author
- Ozaki K; Kubo T; Imaki R; Shinagawa H; Fukaya H; Ohtaki K; Ozaki S; Izumi T; Aizawa Y;
- Institution
- Division of Cardiology, Niigata University Graduate School of Medical & Dental Sciences, Niigata, Japan. k-ozaki@hosp.niigata.niigata.jp
- Journal
- J Atheroscler Thromb. 2006 Aug;13(4):216-9.
- Abstract URL
- Click here to view abstract
20. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
- Author
- Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y;
- Institution
- Lipid Clinic, Medical Department, Rikshospitalet, Oslo, Norway. leiv.ose@klinmed.uio.no
- Journal
- Curr Med Res Opin. 2006 May;22(5):823-35.
- Abstract URL
- Click here to view abstract
Next: Clinical Trials
Previous Section
